Literature DB >> 30601064

Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.

Xia Zheng1, Min Liu2, YingChun Song3, ChunHua Feng4.   

Abstract

OBJECTIVE: Long non-coding RNA-ATB (Lnc-ATB) have been reported to promote tumor proliferation and metastasis via regulation of tumor suppressive miRNA-related signals. Patients with endometrial cancer (EC) have advanced stage disease or metastasis have poor prognosis. We here investigated the role of Lnc-ATB in endometrial cancer.
METHODS: Endometrial cancer tissues and normal tissues (n = 35) were collected to determine the expression and clinical significance of Lnc-ATB, and bioinformatics analysis was used to predict the miRNA target. siRNA was used to estimate the function of Lnc-ATB in EC cell lines and in vivo. RESULT: The expression of Lnc-ATB is up-regulated in tumor tissues and EC cell lines. Patients with high expressed Lnc-ATB have high FIGO stage and poor tumor differentiation. The tumor suppressor miR-126 interacted with Lnc-ATB. Down-regulated miR-126 negative correlated with FIGO stage and tumor differentiation. Knockdown of Lnc-ATB in RL95 and HEC1A cell lines increased the miR-126 level and impaired the cell vitality, induced caspase-3-related tumor apoptosis and G1/S arrest. However, abrogation of miR-126 by its inhibitors counteracted Lnc-ATB knockdown-induced tumor inhibition via regulation of miR-126 target gene PIK3R2 and Sox2-related apoptosis and cell cycle pathway. Meanwhile, Lnc-ATB knockdown also suppressed the migration and invasion and inhibited TGF-β-induced epithelial-mesenchymal transition (EMT) phenotype via miR-126. Knockdown of Lnc-ATB in vivo remarkably induced tumor regression via restoration of tumor suppressor miR-126, leading to deceased tumor volume, reduced expression of PCNA and PIK3R2/Sox2 signals and EMT phenotype in tumor tissues.
CONCLUSION: These data demonstrate the tumorigenic role of Lnc-ATBs in endometrial cancer via abrogation of tumor suppressor miR-126 signals.

Entities:  

Keywords:  EMT; Lnc-ATB; endometrial cancer; miR-126; tumor growth

Mesh:

Substances:

Year:  2019        PMID: 30601064     DOI: 10.1089/cbr.2018.2565

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  5 in total

Review 1.  The function of LncRNA-ATB in cancer.

Authors:  Amir Anbiyaiee; Mohammad Ramazii; Siamak Soltani Bajestani; Seyed Mohammadmahdi Meybodi; Mona Keivan; Seyed Esmaeil Khoshnam; Maryam Farzaneh
Journal:  Clin Transl Oncol       Date:  2022-05-21       Impact factor: 3.405

2.  Genetic Variants miR-126, miR-146a, miR-196a2, and miR-499 in Polycystic Ovary Syndrome.

Authors:  R Li; Y Yu; S O Jaafar; B Baghchi; M Farsimadan; I Arabipour; H Vaziri
Journal:  Br J Biomed Sci       Date:  2022-01-07       Impact factor: 2.432

3.  HCG11 up-regulation induced by ELK4 suppressed proliferation in vestibular schwannoma by targeting miR-620/ELK4.

Authors:  Ruiqing Long; Zhuohui Liu; Jinghui Li; Yuan Zhang; Hualin Yu
Journal:  Cancer Cell Int       Date:  2021-01-05       Impact factor: 5.722

Review 4.  MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.

Authors:  Amélia Favier; Grégoire Rocher; Annette K Larsen; Romain Delangle; Catherine Uzan; Michèle Sabbah; Mathieu Castela; Alex Duval; Céline Mehats; Geoffroy Canlorbe
Journal:  Cancers (Basel)       Date:  2021-03-06       Impact factor: 6.639

5.  The prognostic value of long noncoding RNA activated by TGF-β in digestive system cancers: A meta-analysis.

Authors:  Houyu Duan; Xiang Ding; Hesheng Luo
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.